You are here
SBIR Phase I: Novel injectable long-acting local anesthetic for postoperative pain management
Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 2026176
Agency Tracking Number: 2026176
Amount:
$255,838.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
BM
Solicitation Number:
N/A
Timeline
Solicitation Year:
2020
Award Year:
2020
Award Start Date (Proposal Award Date):
2020-09-01
Award End Date (Contract End Date):
2021-08-31
Small Business Information
825 N 300 W STE 300
SALT LAKE CITY, UT
84103
United States
DUNS:
081318998
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Brett Davis
Phone: (754) 244-8906
Email: bdavi070@fiu.edu
Phone: (754) 244-8906
Email: bdavi070@fiu.edu
Business Contact
Name: Brett Davis
Phone: (754) 244-8906
Email: bdavi070@fiu.edu
Phone: (754) 244-8906
Email: bdavi070@fiu.edu
Research Institution
N/A
Abstract
The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project develops novel pain therapeutics that can reduce or eliminate the use of opioids after surgery. Opioid-based medications are a mainstay of postopera
* Information listed above is at the time of submission. *
